Home Markets US-listed Abivax shares skyrocket on positive phase 3 data for colitis drug US-listed Abivax shares skyrocket on positive phase 3 data for colitis drug Andrew M Jul 23, 2025 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/uslisted-abivax-shares-skyrocket-on-positive-phase-3-data-for-colitis-drug-4147105 Abivax colitis Market Updates www.investing.com/news/stock-market-news/uslisted-abivax-shares-skyrocket-on-positive-phase-3-data-for-colitis-drug-4147105